Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ehave Inc (OP: EHVVF )

0.0015 +0.0005 (+50.00%)
Streaming Delayed Price Updated: 11:30 AM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 250,000
Open 0.0010
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0010
Today's Range 0.0010 - 0.0015
52wk Range 0.0001 - 0.0038
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Combatting The 'Bad Trip': New Research Project Seeks Solutions That Go Beyond Psychedelics
Ehave, Inc. (OTC: EHVVF) has completed the first of three planned phases of its studies with the University of Melbourne to determine the cause and possible cure for hallucinogen-persisting perception... 
Via Benzinga
FDA Green Lights New Study Testing IV Ketamine Infusion For Depressive Disorder
After a full review of healthcare provider Ehave Inc.'s (OTC Pink: EHVVF) IND application, the U.S. 
Via Benzinga

Performance

YTD
+200.00%
+200.00%
1 Month
+50.00%
+50.00%
3 Month
-25.00%
-25.00%
6 Month
-11.76%
-11.76%
1 Year
-44.44%
-44.44%

More News

Read More
Psyched: Christie's Launches NFT Collection Supporting Psychedelic Science, Origin's Listing On CSE Gives Retail Investors Access To Private Companies
Via Benzinga
Ehave Partners With Halugen Life Sciences To Create A Ketamine Precision Medicine Platform For Clinical Research
Via Benzinga
Ehave's Mycotopia Therapies To Merge With Ei.Ventures To Form PSLY.COM
Via Benzinga
Roth Capital Reveals Top Psychedelic Picks in New Industry Report
Via FinancialNewsMedia
Ehave Inc. (Stock Symbol: EHVVF) Announces MetaHealthU Will Enter The Market With A Focus On HPPD
Via AB Newswire
KetaDASH Announces Mobile Ketamine Treatments in San Francisco and Sacramento Area
Via Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
Via Benzinga
Cannabis Movers & Shakers: Greenlight Distribution, Petalfast, Tinley Beverage, Shryne Group, Ehave, NY Cannabis Control Board
Via Benzinga
Topics Cannabis
Exposures Cannabis
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.